@misc{misc, title = {{26875 52-week laboratory safety findings from an open-label extension (OLE) study of dupilumab in adolescent patients with atopic dermatitis (LIBERTY AD PED-OLE)}},
url = {{}},
year = {{2021}},
month = {{9}},
author = {{Cork MJ and Lockshin B and Blauvelt A and Chen Z and Khokhar FA and Bansal A and Prescilla R}},
note = {{Accessed on 2025/07/27}}}